MANGROVE: A Study to Investigate the Efficacy of Zanubrutinib Plus Rituximab Compared With Bendamustine Plus Rituximab in Adults With Previously Untreated Mantle Cell Lymphoma Who Are Ineligible for Stem Cell Transplantation (clinicaltrials.gov) - Oct 1, 2026 - P3 | N=510 | Active, not recruiting | Sponsor: BeOne Medicines | Trial primary completion date: Mar 2027 ➔ Apr 2026
Trial primary completion date • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Transplantation
|